Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Biometric Access Control System Sales to Grow 9.9% Annually Through 2021


September 7, 2017 ( Newswire) Sales of biometric access control systems are projected to increase 9.9% annually to $1.2 billion through 2021. Biometric products will continue to represent the fastest growing product segment through the foreseeable future. These and other trends are presented in Access Controls Market in the US, a new study from The Freedonia Group, a Cleveland-based industry research firm.

Finger and hand technologies represent the largest share of biometric access control sales, accounting for 49% in 2016. Through 2021, demand for finger and hand systems is expected to rise 9.1% per year to $590 million. Among biometric technologies, fingerprint technology has achieved the widest commercialization for access control systems. The long history of fingerprint identification and large pool of existing fingerprint data, in addition to the relatively low cost compared to other biometric technologies, will be important factors for growth. According to analyst Katherine Brink, “Fingerprint technology is expected to remain the market leader for the foreseeable future.”

Sales of all types of access control systems in the US are projected to increase 5.0% per year through 2021 to $4.6 billion. Faster gains will be limited by the end users’ willingness to invest in access control systems. Even as biometric technology comes down in price, the cost of these systems still outweighs the needs of all but the highest security locations. More basic electronic systems compete with mechanical locks, which provide similar levels of security at a lower cost.

Source: The Freedonia Group

Access Controls Market in the US (published 08/2017, 126 pages) is available for $4900 from The Freedonia Group. For further details or to arrange an interview with the analyst, please contact Corinne Gangloff by phone 440.684.9600 or email

Related studies include:

About The Freedonia Group, a division of – The Freedonia Group is a leading international industrial research company publishing more than 100 studies annually. Since 1985, we have provided research to customers ranging in size from global conglomerates to one-person consulting firms. More than 90% of the industrial companies in the Fortune 500 use Freedonia Group research to help with their strategic planning. Additional Security studies can be purchased at, and - investing ideas for Defense stocks, Biometrics stocks, Homeland security stocks, Biodefense stocks, Cyber security stocks

Like Defense and Security Stocks? View our Defense and Security Stocks Directory

Get News Alerts on Defense Stocks

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: